site:www.ajmc.com - Search Videos

Four Pillars of Heart Failure Therapy | AJMC

Four Pillars of Heart Failure Therapy | AJMC

Monitoring Patients With Iron Deficiency Anemia After Diagnosis | AJMC

Monitoring Patients With Iron Deficiency Anemia After Diagnosi…

Abelacimab, a “Game Changer” for High-Risk Patients With AFib: Dr Ruff and Dr Bloomfield Elaborate on Latest Data From AZALEA-TIMI 71 Trial | AJMC

Abelacimab, a “Game Changer” for High-Risk Patients With AFib: Dr R…

Treatment of Heart Failure With ARNI Therapy | AJMC

Treatment of Heart Failure With ARNI Therapy | AJMC

Advancements in CLL: A Conversation With Dr Brian Koffman | AJMC

Advancements in CLL: A Conversation With Dr Brian Koffm…

SGLT2 Inhibitors May Not Protect Against Cardiotoxicity From Cancer Treatment: Rakendu Rajendran, MBBS | AJMC

SGLT2 Inhibitors May Not Protect Against Cardiotoxicity From Canc…

Test Your Knowledge of AI, Medicare, and Prior Authorization Reform | AJMC

Test Your Knowledge of AI, Medicare, and Prior Authorization …

The Evolution of Transgender Health Care | AJMC

Understanding the Burden of Menopausal Vasomotor Symptom…

Overview of the Hurley Staging System for Hidradenitis Suppurati…

Oncology Pharmacists Are Bridging Gaps in Cancer Care: Jasmine Eu…

Payer and Prior Authorization Barriers | AJMC

Sickle Cell Disease: Treatment Goals and Guidelines | AJMC

HIV Therapy Without Integrase Inhibitor: Practical Advantages an…

Incidence and Prevalence of MDS Across Patient Populations | AJMC

Brensocatib Could Change the Landscape of Bronchiectasis Trea…

Recognizing Risk and the Broader Health Impact in MASH | AJMC

Navigating Insurance Hurdles and Policy Shortfalls in Breast Cancer …

Nerandomilast a "No-Brainer" for First-Line Pulmonary Fibrosis The…

Predicting Patient Response in the Move Toward Precision Medicine i…

Exploring the Future of COPD Care With AI-Guided Therapy: Christop…

Next Steps: Post-Frontline Therapies and Resistance in ALK …

Trispecific Antibodies on the Horizon | AJMC

FRα Biomarker Testing in Patients With Ovarian Cancer | AJMC

Improving Clinical Trial Diversity by Building Trust: Melanie Sheen, M…

Long-Term Impact of Bronchiectasis Exacerbations: Disease Progressi…

Incidence and Prevalence For ILD | AJMC

Key Considerations in COPD When Utilizing Combination Therapy | A…

History of Mergers and Acquisitions in the Healthcare Industry | AJMC

Effect of Fexofenadine HC1 on Quality of Life and Work, Classroo…

See more videos